[CLDX] QoQ Quarter Result on 31-Dec-2010 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- 349.38%
YoY- 275.08%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 2,363 1,952 2,516 37,721 2,408 2,951 3,713 -25.99%
PBT -11,334 -9,802 -9,574 23,046 -8,755 -9,191 -6,245 48.73%
Tax -288 -158 -268 1,449 -248 -190 -6,324 -87.22%
NP -11,772 -10,236 -10,059 22,661 -9,087 -9,525 -6,582 47.29%
Tax Rate - - - -6.29% - - - -
Total Cost 14,135 12,188 12,575 15,060 11,495 12,476 10,295 23.50%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin -498.18 -524.39 -399.80 60.08 -377.37 -322.77 -177.27 99.01%
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
EPS -4.00 -4.10 -4.71 10.61 -4.27 -4.49 -3.11 18.24%
EPS Diluted -4.00 -4.10 -4.71 10.61 -4.27 -4.49 -3.11 18.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.